CD1D and mantle cell lymphoma: Moreover, Tiper and Webb also demonstrated that Trichostatin-A, a pan-HDACi enhanced both CD1d- and MHC class II-mediated antigen presentation in mantle cell lymphoma (MCL), as well as inhibiting STAT3-regulated inflammatory cytokine secretion by MCL cells (Tiper and Webb, 2016).